ExploreWatchlistsPricing
  1. JP-listed companies
  2. StemCell Institute Inc.
  3. Financials
  4. Retained earnings

StemCell Institute Inc. (7096)

Market cap
¥6.8B
P/E ratio
64x
Stemcell Research Institute stores umbilical cord blood and tissue for expecting families, preserving stem cells for potential future medical treatments.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Mar 31, 20261,595+10.18%
Mar 31, 20251,448+9.83%
Mar 31, 20241,318+30.87%
Mar 31, 20231,007+24.47%
Mar 31, 2022809+17.72%
Mar 31, 2021688+9.98%
Mar 31, 2020625+79.80%
Mar 31, 2019348

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat